Johan Wedell-Wedellsborg, Director, 10% Owner at Y-mAbs Therapeutics, Inc. (YMAB), sold 178,232 shares at $26.58 ($4.7M) on 2019-08-29, disclosed to the SEC on 2019-09-03.
Open-market sale of $4.7M YMAB by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.58 | 89,066 | $2.4M | 50.0% |
| 2 | $26.58 | 89,066 | $2.4M | 50.0% |
| 3 | $27.00 | 100 | $3K | 0.1% |
| Total | $26.58 avg | 178,232 | $4.7M | 100% |
| Filing → |
| YMAB | BUY | 2023-12-01 | $619K | — | Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |